Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3889

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis

Pedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, Divaya Bhutani, Shannon Miller, Annemarie Rossi, Sarah AM Cuddy, Rodney H Falk, Suzanne Lentzsch, Jacob Laubach, Giada Bianchi

Blood blood.2025028383.

https://doi.org/10.1182/blood.2025028383

Published: 2025

Includes: Supplemental data

Journal Articles

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael Pratta, Rodica Morariu-Zamfir, John F. DiPersio

Blood (2025) 146 (4): 422–436.

https://doi.org/10.1182/blood.2024026586

Published: 2025

Includes: Supplemental data

Journal Articles

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Blood (2025) 146 (4): 456–470.

https://doi.org/10.1182/blood.2024025875

Published: 2025

Includes: Supplemental data

Journal Articles

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

John G. Howe, Gary Stack

Blood (2025) 146 (4): 504–517.

https://doi.org/10.1182/blood.2024025071

Published: 2025

Includes: Supplemental data

Journal Articles

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Sara K. Silbert, Alexander W. Rankin, Chloe N. Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova, Hao-Wei Wang, Alexandra E. Kovach, Constance M. Yuan, Dana Delgado Colon, Loïc Vasseur, Alex Bataller, Samuel John, Kaylyn Utley Lyons, Barbara Friedes, Anna Alonso-Saladrigues, Hisham Abdel-Azim, Estelle Balducci, Ahmed Assim Aljudi, Marie Balsat, D. Nathan Biery, Aghiad Chamdin, Bill H. Chang, Raymund S. Cuevo, Barbara De Moerloose, David S. Dickens, Ulrich Duffner, Nicolas Duployez, Firas El Chaer, Michelle Ann Elliott, Gabriele Escherich, Sneha Fernandes, Mandi R. Fitzjohn, Zhubin Gahvari, Stephan A. Grupp, Rui Rochelle He, Cynthia Harrison, Christopher B. Hergott, Emily M. Hsieh, Annette S. Kim, Dennis J. Kuo, Daniel P. Larson, Benjamin J. Lee, Thibaut Leguay, R. Coleman Lindsley, Abhishek A. Mangaonkar, Kerstin Mezger, Holly L. Pacenta, Jing Pan, Marlie Provost, Latika Puri, Sunil S. Raikar, Armando Martinez, Isabella Bristol, Kyle Murphy, Lauren Reiman, Michele Redell, Kelly Reed, Gabrielle Roth-Guepin, Jeremy Rubinstein, Süreyya Savaşan, Kristian Schafernak, Alexandra Stevens, Aimee Talleur, Naomi Torres Carapia, Jacques Vargaftig, Anant Vatsayan, Matthias Wölfl, Liping Zhao, Susana Rives, Vanessa A. Fabrizio, Koji Sasaki, Ibrahim Aldoss, Nicolas Boissel, Susan R. Rheingold, Kara L. Davis, Sara Ghorashian, Elad Jacoby, Alexander Popov, Adam J. Lamble, Nirali N. Shah

Blood (2025) 146 (4): 437–455.

https://doi.org/10.1182/blood.2024026655

Published: 2025

Includes: Supplemental data

Journal Articles

Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease

Blood blood.2025028562.

https://doi.org/10.1182/blood.2025028562

Published: 2025

Includes: Supplemental data

Journal Articles

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

Debasmita Dutta, Jiye Liu, Kenneth Wen, Arghya Ray, Alessandro Salatino, Xiangdong Liu, Annamaria Gulla, Teru Hideshima, Yan Song, Kenneth C. Anderson

Blood blood.2025028597.

https://doi.org/10.1182/blood.2025028597

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world data provide a CARbon copy for ide-cel

Timothy Schmidt

Blood (2025) 146 (2): 131–133.

https://doi.org/10.1182/blood.2025029274

Published: 2025

Journal Articles

Silence of the myeloma clones: GPRC5D epigenetic regulation

Holly Lee, Nizar J. Bahlis

Blood (2025) 146 (2): 133–135.

https://doi.org/10.1182/blood.2025028865

Published: 2025

Journal Articles

Beware the zombie enzyme

David Dominguez-Sola

Blood (2025) 146 (2): 135–136.

https://doi.org/10.1182/blood.2025028953

Published: 2025

Journal Articles

Iron overload impacts TCR γδ cell immunity

José Pedro Loureiro, M. Fátima Macedo

Blood (2025) 146 (2): 139–140.

https://doi.org/10.1182/blood.2025029261

Published: 2025

Journal Articles

The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Cs a /Cs b red cell antigens

Blood (2025) 146 (2): 247–253.

https://doi.org/10.1182/blood.2024026285

Published: 2025

Includes: Supplemental data

Journal Articles

Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma

Blood (2025) 146 (2): 178–190.

https://doi.org/10.1182/blood.2024026622

Published: 2025

Includes: Supplemental data

Journal Articles

Iron overload in HFE-related hemochromatosis severely impairs Vδ2 + γδ T-cell homeostasis

Derya Erdogdu, Ina Becoku, Valerie Huber, Yao Wang, Matthias Eyrich, Hisayoshi Hashimoto, Michaela Döring, Johannes Schulte, Karin Schilbach

Blood (2025) 146 (2): 219–232.

https://doi.org/10.1182/blood.2024025345

Published: 2025

Includes: Supplemental data

Journal Articles

Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma

Blood (2025) 146 (2): 167–177.

https://doi.org/10.1182/blood.2024026216

Published: 2025

Includes: Supplemental data

Journal Articles

Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens

Blood blood.2024027616.

https://doi.org/10.1182/blood.2024027616

Published: 2025

Includes: Supplemental data

Journal Articles

Blunted CD40-responsive enhancer activation in CREBBP -mutant lymphomas can be restored by enforced CD4 T-cell engagement

Blood (2025) 146 (2): 191–205.

https://doi.org/10.1182/blood.2024026664

Published: 2025

Includes: Supplemental data

Journal Articles

IFN-γ promotes the progression of iMCD by activating inflammatory monocytes

Blood (2025) 146 (1): 76–88.

https://doi.org/10.1182/blood.2024027689

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat Wiskott-Aldrich syndrome

Tanja C. Vallée, Michael H. Albert, Sung-Yun Pai

Blood (2025) 146 (1): 41–51.

https://doi.org/10.1182/blood.2024026288

Published: 2025

Includes: Supplemental data

Journal Articles

Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy

Carolyn Shasha, David R. Glass, Ernest Moelhman, Laura Islas, Yuan Tian, Tony Chour, Guoyue Xu, Gregory L. Szeto, Tao Peng, Xiaoling Song, Michelle Wurscher, Andrew J. Cowan, Thomas F. Bumol, Troy R. Torgerson, Philip D. Greenberg, Damian J. Green, Evan W. Newell

Blood (2025) 145 (26): 3113–3123.

https://doi.org/10.1182/blood.2024025655

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

Real-world data provide a CARbon copy for ide-cel

Silence of the myeloma clones: GPRC5D epigenetic regulation

Beware the zombie enzyme

Iron overload impacts TCR γδ cell immunity

The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Cs a /Cs b red cell antigens

Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma

Iron overload in HFE-related hemochromatosis severely impairs Vδ2 + γδ T-cell homeostasis

Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma

Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens

Blunted CD40-responsive enhancer activation in CREBBP -mutant lymphomas can be restored by enforced CD4 T-cell engagement

IFN-γ promotes the progression of iMCD by activating inflammatory monocytes

How I treat Wiskott-Aldrich syndrome

Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only